NCT04973228 · Interventional trial
Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM)
Overall registry status Completed
Phase 3
Conditions Seborrheic Dermatitis
Delaware Valley sites
- Arcutis Biotherapeutics Clinical Site 08 · Broomall, PA · Delaware County
- Arcutis Biotherapeutics Clinical Site 34 · East Windsor, NJ · Mercer County
First posted
Registry updated
Added to the directory